首页> 美国卫生研究院文献>BMJ Open >Values preferences and burden of treatment for the initiation of GLP-1 receptor agonists and SGLT-2 inhibitors in adult patients with type 2 diabetes: a systematic review

【2h】

Values preferences and burden of treatment for the initiation of GLP-1 receptor agonists and SGLT-2 inhibitors in adult patients with type 2 diabetes: a systematic review

机译：在2型糖尿病患者中引发GLP-1受体激动剂和SGLT-2抑制剂的价值偏好和治疗负担：系统评价

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

Assess values, preferences and burden of treatment that patients with type 2 diabetes consider when initiating glucagon-like peptide-1 receptor agonists (GLP-1 RA) or sodium-glucose cotransporter-2 inhibitors (SGLT-2i) compared with other glucose-lowering options.

机译：在与其他葡萄糖降低相比，评估2型糖尿病患者的评估患者患者的糖尿病患者考虑患者的糖尿病患者的治疗患者，例如，与其他葡萄糖降低相比，糖蛋白样肽-1受体激动剂（GLP-1Ra）或钠 - 葡萄糖COTRANSPORPOR-2抑制剂（SGLT-2I）选项。

著录项

期刊名称 BMJ Open
作者
José Gerardo González-González; Alejandro Díaz González-Colmenero; Juan Manuel Millán-Alanís; Lyubov Lytvyn; Ricardo Cesar Solis; Reem A Mustafa; Suetonia C Palmer; Sheyu Li; Qiukui Hao; Neri Alejandro Alvarez-Villalobos; Per Olav Vandvik; René Rodríguez-Gutiérrez;
展开▼
作者单位

展开▼
年(卷),期 2021(11),7
年度 2021
页码 e049130
总页数 13
原文格式 PDF
正文语种
中图分类
关键词

机译：糖尿病和内分泌学;一般内分泌学;一般糖尿病;

相似文献

外文文献
中文文献
专利

1. Cardiovascular and renal outcomes with SGLT-2 inhibitors versus GLP-1 receptor agonists in patients with type 2 diabetes mellitus and chronic kidney disease: a systematic review and network meta-analysis [J] . Takayuki Yamada, Mako Wakabayashi, Abhinav Bhalla, Cardiovascular Diabetology . 2021,第1期

机译：具有SGLT-2抑制剂的心血管和肾果糖与2型糖尿病患者GLP-1受体激动剂，慢性肾病：系统审查和网络元分析
2. Erratum to: Pharmacokinetics, safety, and efficacy of DPP-4 inhibitors and GLP-1 receptor agonists in patients with type 2 diabetes mellitus and renal or hepatic impairment. A systematic review of the literature [J] . Carlo B. Giorda, Elisa Nada, Barbara Tartaglino Endocrine. . 2014,第3期

机译：勘误：DPP-4抑制剂和GLP-1受体激动剂在2型糖尿病和肾或肝功能不全患者中的药代动力学，安全性和有效性。对文献的系统回顾
3. Pharmacokinetics, safety, and efficacy of DPP-4 inhibitors and GLP-1 receptor agonists in patients with type 2 diabetes mellitus and renal or hepatic impairment. A systematic review of the literature [J] . Carlo B. Giorda, Elisa Nada, Barbara Tartaglino Endocrine. . 2014,第3期

机译：DPP-4抑制剂和GLP-1受体激动剂在2型糖尿病和肾或肝功能不全患者中的药代动力学，安全性和有效性。对文献的系统回顾
4. Treatment of Diabetes and Obesity by Rationally Designed Peptide Agonists Functioning at Multiple Metabolic Receptors [C] . Noushafarin Khajavi, Heike Biebermann, Matthias Tschop, ESPE Advanced Seminar in Developmental Endocrinology . 2017

机译：通过在多种代谢受体中起作用的合理设计肽激动剂治疗糖尿病和肥胖症
5. Reduction of Angiotensin II Induced Hypertension and Cardiac Fibrosis with GLP-1 Receptor Agonist and DPP-4 Inhibitor via Decreasing NADPH Oxidase Expression [D] . Banks, Trenton Edward. 2020

机译：通过降低NADPH氧化酶表达，通过降低NADPH-1受体激动剂和DPP-4抑制剂减少血管紧张素II诱导的高血压和心肌纤维化
6. Response to Letter to the Editor Regarding: Patient Preferences for Glucagon-like Peptide-1 (GLP-1) Receptor Agonist Treatment of Type 2 Diabetes Mellitus in Japan: A Discrete Choice Experiment [O] . Anne B. Brooks, Jakob Langer, Tommi Tervonen, 2020

机译：回应关于编辑的信函：患者偏好的胰高血糖素肽-1（GLP-1）受体激动剂治疗日本2型糖尿病：一个离散的选择实验
7. Cardiovascular and renal outcomes with SGLT-2 inhibitors versus GLP-1 receptor agonists in patients with type 2 diabetes mellitus and chronic kidney disease: a systematic review and network meta-analysis [O] . Takayuki Yamada, Mako Wakabayashi, Abhinav Bhalla, 2021

机译：患有SGLT-2抑制剂的心血管和肾果剂与2型糖尿病患者的GLP-1受体激动剂和慢性肾病：系统审查和网络META分析

Values preferences and burden of treatment for the initiation of GLP-1 receptor agonists and SGLT-2 inhibitors in adult patients with type 2 diabetes: a systematic review

摘要

著录项

相似文献

相关主题

期刊订阅